Evoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Rating) in a research report report published on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Performance EVOK stock opened at $2.31 on Thursday. The company has a debt-to-equity ratio of 1.22, a quick ratio of […]